Medical Cannabis: Implications for Prescription Drugs, Health Care and Consumer Goods

New insights for key industries impacted by the growth of medical marijuana into the reasons why patients choose cannabis as an alternative or addition to other health-and-wellness products

Supplier:

Aclara Research

Message

100% funded

10% for you,
10% for your friend

About

Illinois was the 20th state to establish a medical-marijuana program. The growing wave of legalization and normalization of cannabis usage has resulted in changing consumer attitudes and behaviors. Patients have begun to swap certain health-and-wellness products for medical marijuana. This trend is at its beginning and its impact on prescription drugs and countless items in the health-and-wellness aisles is only going to grow.

Objectives

  • Identify characteristics of cannabis patients (in Illinois) and why they are using medical marijuana
  • Understand how medical cannabis impacts prescription-drug usage
  • Quantify the methods (vaping, edibles, etc.) patients use to consume medical cannabis for symptom relief
  • Analyze the overall shopping experience of selecting and buying medical cannabis products
  • Learn from Illinois as a roadmap for future expanded medical marijuana use as a result of its highly stringent regulations

Why?

Within this study of a single medical cannabis market, you'll discover key need states that drive cannabis consumption and impact more than 130-million adults impacted by chronic-pain conditions.

This study of Illinois -- one of the most restrictive medical-cannabis states in the country -- illuminates usage trends with far-reaching implications across adjacent categories and services:

• OTC medications ($34 billion – 2016 retail sales - CHPA)
• Vitamin supplements ($27.6 billion – 2016 retail sales – Euromonitor)
• Prescription drugs ($424 billion – 2015 retail, mail & amp; non-retail sales – IMS Health)
• In-store pharmacy retailers ($208 billion – 2015 chain, independents & grocery store pharmacies – IMS)

Email info@collaborata.com to schedule a call with the research leaders. (Click link below to read National Pain Report article about this study: http://nationalpainreport.com/illinois-medical-cannabis-patient-study-shows-positive-impact-on-pain-8833677.html)
Within this study of a single medical cannabis market, you'll discover key need states that drive cannabis consumption and impact more than 130-million adults impacted by chronic-pain conditions.

This study of Illinois -- one of the most restrictive medical-cannabis states in the country -- illuminates usage trends with far-reaching implications across adjacent categories and services:

• OTC medications ($34 billion – 2016 retail sales - CHPA)
• Vitamin supplements ($27.6 billion – 2016 retail sales – Euromonitor)
• Prescription drugs ($424 billion – 2015 retail, mail & amp; non-retail sales – IMS Health)
• In-store pharmacy retailers ($208 billion – 2015 chain, independents & grocery store pharmacies – IMS)

Email info@collaborata.com to schedule a call with the research leaders. (Click link below to read National Pain Report article about this study: http://nationalpainreport.com/illinois-medical-cannabis-patient-study-shows-positive-impact-on-pain-8833677.html)

Comments

Add Comment

Error: You must enter text in the box below.

X